Show Stocks and Investing Publications • Tue, April 4, 2023
Michelle Gilson Maintained (VIR) at Hold with Increased Target to $27 on, Apr 4th, 2023
lson-maintained-vir-at-hold-with-increased-target-to-27-on-apr-4th-2023.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAIMichelle Gilson of Morgan Stanley, Maintained "Vir Biotechnology, Inc." (VIR) at Hold with Increased Target from $25 to $27 on, Apr 4th, 2023.
Michelle has made no other calls on VIR in the last 4 months.
There are 6 other peers that have a rating on VIR. Out of the 6 peers that are also analyzing VIR, 1 agrees with Michelle's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Michael Ulz of "Morgan Stanley" Upgraded from Sell to Hold and Increased Target to $30 on, Friday, January 27th, 2023
These are the ratings of the 5 analyists that currently disagree with Michelle
- Eric Joseph of "JP Morgan" Upgraded from Hold to Buy and Decreased Target to $34 on, Monday, March 6th, 2023
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $100 on, Monday, March 6th, 2023
- Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $32 on, Friday, February 24th, 2023
- Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $53 on, Thursday, February 23rd, 2023
- Roanna Ruiz of "SVB Leerink" Maintained at Buy with Decreased Target to $43 on, Friday, January 27th, 2023